Absorption |
Blood-Brain Barrier | BBB+ | 0.9734 |
Human Intestinal Absorption | HIA+ | 0.9066 |
Caco-2 Permeability | Caco2+ | 0.7072 |
P-glycoprotein Substrate | Non-substrate | 0.8974 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9855 |
Non-inhibitor | 0.9901 |
Renal Organic Cation Transporter | Non-inhibitor | 0.9276 |
Distribution |
Subcellular localization | Lysosome | 0.5679 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8443 |
CYP450 2D6 Substrate | Non-substrate | 0.8305 |
CYP450 3A4 Substrate | Non-substrate | 0.8202 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8651 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8794 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9512 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9238 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9814 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8279 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9569 |
Non-inhibitor | 0.9708 |
AMES Toxicity | Non AMES toxic | 0.9531 |
Carcinogens | Carcinogens | 0.6204 |
Fish Toxicity | High FHMT | 0.6154 |
Tetrahymena Pyriformis Toxicity | Low TPT | 0.6809 |
Honey Bee Toxicity | High HBT | 0.8554 |
Biodegradation | Not ready biodegradable | 0.5107 |
Acute Oral Toxicity | III | 0.5781 |
Carcinogenicity (Three-class) | Non-required | 0.5215 |